Papers Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Optogenetic stimulation of a hippocampal engram activates fear memory recall (Liu)

Know, Gap, Hypothesis

A

Know: memory encode by neurons that can be tagged for identification, inactivation= reduced memory

Gap: Can you elicit behavioral output of specific memory by directly activating population of neurons active during learning?

Hypothesis: Reactivation neurons active during freezing = reduce memory expression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Optogenetic stimulation of a hippocampal engram activates fear memory recall (Liu)

Methods

A

Optogenetics- genetically engineer animals.
Labelled with ChR2

  1. Box (no fear)
  2. Shock box - label fear neurons
  3. Animal back in original box, shine light it becomes scarred
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Optogenetic stimulation of a hippocampal engram activates fear memory recall (Liu)

IV, DV

A

IV:
Fear + ChR2 expression
No Fear + ChR2 expression
Fear + Florescent Yellow Protein

DV: Freezing behavior

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Optogenetic stimulation of a hippocampal engram activates fear memory recall (Liu)

Results and Conclusions

A

optogenetic reactivation of hippocampal neurons activated during fear sufficient to induce freezing behavior.

Increase only upon light stimulation, only in Fear + ChR2

Activation of that engram causes animal to freeze in context it wasn’t afraid of

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Rapid decrease in depression symptoms with N-methyl in ECT resistant… (Ibrahim)

Know, Gap, Hypothesis

A

Know: Ketamine improves symptoms in treatment resistant, acts rapidly

Gap: Equally effective in those who have had ETC?

Hypothesis: Is it as effect in patients whose depression doesn’t respond?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rapid decrease in depression symptoms with N-methyl in ECT resistant… (Ibrahim)

Methods, IV, DV

A
  1. Everyone gets 0.5 mg/kg ketamine
  2. MADRS and CADSS 60 minutes before and in intervals afterwards

IV: did not respond to ETC vs. did not receive ETC
DV: how they responded on MADRS and CADSS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Rapid decrease in depression symptoms with N-methyl in ECT resistant… (Ibrahim)

Results/Conclusions

A
  1. Both groups decrease depressive symptoms
  2. Group without ECT previously had greater symptom decrease that group that did have ETC

Appears to improve symptoms.
Confound: Hospitalization (future direction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

FGF2 augmentation early in life alters hippocampal development… anxiety phenotype (TURNER)

Known, Gap, Methods

A

Known: Mood disorders have altered FGF2, disrupted in anxiety, involved with connectivity. Decrease in anxiety

Gap: Are these a cause or consequence?

Hypothesis: FGF2 given a day after birth has long-lasting effects on hippocampal development and emotionality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

FGF2 augmentation early in life alters hippocampal development… anxiety phenotype (TURNER)

Methods

A
  1. Breed high/low responders
  2. FGF2 injections
  3. Markers in hippocampus (see below)
    Used Laser capture microscopy and microarray analysis (reveal expressed genes)

Stained with…
BrdU- newly synthesized DNA
KI67- nuclear protein associated with proliferation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

FGF2 augmentation early in life alters hippocampal development… anxiety phenotype (TURNER)

Results

A

FGF2 increased proliferation in subgranular zone of dentate gyrus and cell survival in granule cell layer

BrdU and KI67 both increase in FGF2 rats

  1. Behavioral: more time in light box/open arms, decrease latency to enter
  2. Genetic: increases Ntrk3 and BCL212 expression, up regulated genes for cell survival, down regulated anxiety genes
  3. Neural: FGF2 increase cell survival in dentate gyrus 3 weeks later/ cell proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

FGF2 augmentation early in life alters hippocampal development… anxiety phenotype (TURNER)

Conclusions

A

FGF2 involved in develop of hippocampus and modulation of anxiety behavior.

Potential downstream targets for anxiety

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SWS during daytime nap…interference and LTP (Alger)

Known, Gap, Hypothesis

A

Known: sleep facilitates processing of newly acquired declarative info. Hippocampal activation during sleep contingent on acquisition level during training

Gap: what type/length of sleep needed for declarative memory?

Hypothesis: SWS obtained to consolidate declarative memory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

SWS during daytime nap…interference and LTP (Alger)

Methods, IV, DV

A
  1. Bimodal pairs (36 total)
  2. Sleep - 9 electrodes
  3. Retested
  4. Interference
  5. Retested
  6. 1 week later- another SSS, ask about 10 learned items

IV: 10 min, 60 min, wake
DV: % Correct each test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

SWS during daytime nap…interference and LTP (Alger)

Results/Conclusions

A

Both naps groups better at short term retention

10 min effects temporary, interference blocks it

SWS activity facilitates consolation of learning bimodal pairs
ACTIVE ROLE OF SLEEP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Synaptic Scaling Across Sleep/Wake Cycle (De Vivo)

Know, Gap

A

Know:

  1. Correlations between ASI/spine size, etc.
  2. Changes in synaptic strength primary mechanisms for learning/memory
  3. Potentiation/depression must balance to avoid saturation/obliteration of neural signals

Gap: Does synaptic strength/weakening happen throughout learning when awake or during wake/sleep

Depression- sleep
Potentiation- wake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Synaptic Scaling Across Sleep/Wake Cycle (De Vivo)

Hypothesis

A

Sleep renormalizes synaptic strength increased by wake

  1. Excitatory synapses increase in size after wake, decrease after sleep
  2. Synaptic renormalization should be selective to allow for stability and plasticity
17
Q

Synaptic Scaling Across Sleep/Wake Cycle (De Vivo)

Methods, IV, DV

A

3D electron microscopy (SBEM)
Sampled layer 2 of primary motor/somatosensory cortex

IV:
S- 75% light period asleep
EW- enforced awake (exposure to novel objects)
SW- spontaneous awake (70% dark period spontaneously wake)

DV: ASI size, similar to postsynaptic density

18
Q

Synaptic Scaling Across Sleep/Wake Cycle (De Vivo)

Results/Conclusions

A

ASI size declines in sleep due to synaptic scaling

What ESCAPES this?

1) Large
2) Crowded
3) No Endosomes

Decline greatest in those with low synaptic density

sleep reemphasizes basic underlying structure.